Hudock Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

Hudock Inc’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$233K	Buy	+470	New	+$208K	0.03%	199
2022 Q4	–	Sell	-164	Closed	-$47K	–	737
2022 Q3	$47K	Hold	164	–	–	0.02%	318
2022 Q2	$46K	Hold	164	–	–	0.02%	317
2022 Q1	$42K	Hold	164	–	–	0.01%	341
2021 Q4	$36K	Hold	164	–	–	0.01%	364
2021 Q3	$29K	Buy	164 +100	+156%	+$19.5K	0.01%	401
2021 Q2	$12K	Hold	64	–	–	﹤0.01%	518
2021 Q1	$13K	Hold	64	–	–	﹤0.01%	502
2020 Q4	$15K	Sell	64 -10	-14%	-$2.29K	﹤0.01%	464
2020 Q3	$20K	Hold	74	–	–	0.01%	382
2020 Q2	$21K	Hold	74	–	–	0.01%	367
2020 Q1	$17K	Buy	+74	New	+$17K	0.01%	353

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Hudock Inc's VRTX Position: Q2 2026 in Review

Hudock Inc opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 470 shares worth $233K. The stake represents 0.03% of the portfolio and ranks #199 among its holdings. This is a return to the name: Hudock Inc previously reported a position in VRTX as recently as Q3 2022.

Hudock Inc first reported a position in VRTX in Q1 2020 and has held it in 12 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Hudock Inc held 470 shares of Vertex Pharmaceuticals worth $233K as of Q2 2026.
Vertex Pharmaceuticals was a new Hudock Inc position in Q2 2026.
Vertex Pharmaceuticals made up 0.03% of Hudock Inc's portfolio in Q2 2026, its #199 holding.
Hudock Inc first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 12 quarters since.
1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Hudock Inc's 13F filing for Q2 2026, filed 31 Jul 2026.